CTOs on the Move

Delcath

www.delcath.com

 
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company`s proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In the United States, the PHP system is being developed under the tradename HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), or HEPZATO, and is considered a combination drug and device product regulated by the United States Food and Drug Administration (FDA).
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.delcath.com
  • 1633 Broadway 22nd Floor, Suite C
    New York, NY USA 10019
  • Phone: 212.489.2100

Executives

Name Title Contact Details

Funding

Delcath raised $35M on 06/07/2016
Delcath raised $20M on 07/23/2019
Delcath raised $22.2M on 12/11/2020

Similar Companies

Rx Systems

Rx Systems is a Saint Charles, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Human Care Systems, Inc.

HCS designs and delivers technology driven therapy management to improve patient initiation, adherence, and persistence. Since 2008, HCS has worked with biopharma brand teams who want to deliver personalized, omni-channel programming with measured outcomes.

Medsource RX

Medsource RX is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Applied Medical

Applied Medical - Corporate Site

Athira

At Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer`s, so that patients can regain their memories, lives, and family relationships. We are a motivated, impassioned team committed to making a positive impact on human health.